pharmaceutical compositions containing the ester, 4 - (2 metilamminoetil) 1, 2 - fenilenicodellyacido 2 - metilpropanoico for the treatment of neurootticopatia glaucomatosa

摘要

Use of Ibopamine, i.e. 4-[2-(methyl-amino)-ethyl]-1,2-phenylene ester of 2-methylpropanoic acid, or a pharmaceutically acceptable acid addition salt thereof for the manufacture of a pharmaceutical composition for the treatment of glaucomatous optic neuropathy is described.